Procedure Deep-Dive · November 19, 2026

Porphyria and Cosmetic Surgery: Photosensitivity, Lasers, IPL, Operating Room Lights, Anesthesia Drugs, EPP, PCT, and Acute Attacks

Porphyria is not one disease but a family of them, and the two halves of the family threaten a cosmetic patient in completely different ways. The skin forms make light itself the hazard, including the light from an IPL handpiece, a blue LED panel, and the surgical lamp overhead. The acute forms turn fasting, hormones, and the wrong anesthetic into the trigger for an attack that can mimic a surgical emergency. Here is what patients and surgeons need to sort out before anyone picks up a laser or a syringe.

By The Editorial Desk

16 min read

A young woman with shoulder-length copper hair, wearing a wide-brimmed straw sun hat with a navy band and a loose light-blue linen shirt, seated in a wooden chair on a shaded white porch beside a window, one hand resting on an open notebook next to a glass of water on a small round wooden table, green trees softly blurred behind her

He is 52 and wants the brown spots and the coarse texture on the backs of his hands and his cheeks treated before his daughter's wedding. He mentions, almost in passing, that the skin on his hands tears if he bumps it, that small blisters come up after a weekend of yard work, and that he has been plucking dark hairs from his upper cheeks for a year. He drinks most nights. He was told years ago that he had "a liver thing" and never followed up. The med spa he called first offered him a package of intense pulsed light sessions and a series of blue-light treatments for "sun damage."

Every detail in that paragraph points to porphyria cutanea tarda, the most common porphyria in adults, and every treatment in that package shines exactly the kind of light his skin cannot tolerate. A different patient, a 29-year-old woman booking a breast augmentation, carries the other half of the problem: she was diagnosed with acute intermittent porphyria after an emergency room visit for abdominal pain at 23, and her attacks have followed crash diets and a course of an antibiotic. For her, the danger is not the lamp. It is the fasting before surgery, the drugs in the anesthesia cart, and the progesterone in the birth control pill her surgeon never asked about.

These two patients share a name for their condition and almost nothing else. That is the first thing anyone planning cosmetic treatment around porphyria has to understand.

What porphyria is, and why it splits into two different problems

The short answer: the porphyrias are a group of rare inherited or acquired disorders of heme production, and they divide into cutaneous forms, where porphyrins build up in the skin and make light harmful, and acute hepatic forms, where precursors build up in the liver and cause neurological attacks triggered by drugs, fasting, and hormones.

Heme is the iron-carrying molecule at the center of hemoglobin and of many liver enzymes. The body builds it in eight steps, each run by a different enzyme. When one of those enzymes works poorly, the material upstream of the blockage accumulates. Which material accumulates, and where, decides what the disease looks like.

The cutaneous porphyrias pile up porphyrins, molecules that absorb light intensely and then release that energy as tissue-damaging reactive oxygen. The main members are:

  • Porphyria cutanea tarda (PCT): the most common porphyria overall. It produces fragile skin, blisters, erosions, scarring, small white milia, darkening, and extra facial hair on sun-exposed areas, especially the backs of the hands, forearms, and face. Most cases are acquired rather than inherited, and they are driven by factors that load the liver with iron or stress it, including alcohol, hepatitis C, HIV, estrogen, smoking, and variants in the HFE gene behind hereditary hemochromatosis.
  • Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP): the most common porphyrias in children. Protoporphyrin builds up in red blood cells and skin, and sunlight causes severe burning pain within minutes, often with swelling but usually without blisters. The skin can look almost normal afterward, which is why patients are frequently disbelieved for years.
  • Congenital erythropoietic porphyria (CEP): very rare and severe, with blistering, scarring, and mutilating skin damage from early childhood.

The acute hepatic porphyrias pile up the earlier building blocks, aminolevulinic acid (ALA) and porphobilinogen (PBG), which are neurotoxic. The main member is acute intermittent porphyria (AIP). Two others, variegate porphyria (VP) and hereditary coproporphyria (HCP), can cause both acute attacks and PCT-like blistering, which makes them the most demanding porphyrias for any surgical plan. An attack can bring severe abdominal pain, nausea and vomiting, constipation, a racing heart, high blood pressure, low sodium, dark or reddish urine, anxiety or confusion, seizures, and in severe cases a weakness that can progress to paralysis.

The American Porphyria Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases both stress the same point about AIP: many people who carry the gene never have an attack. Penetrance is low. Attacks happen when a carrier meets a trigger, and elective surgery assembles several of the classic triggers in one week.

"Porphyria is two hazards wearing one name. In the skin forms, the light is the problem. In the acute forms, the fasting, the hormones, and the drug list are the problem."

So the first question in any consultation is not "do you have porphyria?" but "which porphyria, confirmed by what test, and when was your last flare or attack?" A patient who says "I have porphyria" without a type should be sent back for a definitive diagnosis before elective work. The laboratory workup (urine, stool, and blood porphyrins, plus genetic testing) is not something a cosmetic practice should improvise, which is a broader point we make in our piece on preoperative testing before cosmetic surgery.

Lasers, IPL, blue light, and photodynamic therapy in the skin porphyrias

The short answer: porphyrins absorb most strongly in the violet-blue range around 400 to 410 nanometers, so blue LED panels, broadband IPL with short cutoff filters, and especially photodynamic therapy with aminolevulinic acid carry real risk in PCT and EPP, while longer-wavelength lasers are less directly hazardous but still demand caution on fragile, sun-vulnerable skin.

The physics here is unusually clean. Porphyrins have a sharp absorption peak called the Soret band, centered near 405 to 410 nanometers, which is visible violet light just past the edge of ultraviolet. That is why EPP patients burn behind window glass and on overcast days: ordinary glass and most chemical sunscreens block ultraviolet, not visible violet. It is also why several popular aesthetic devices are a poor match for these patients.

Start with the treatment that is closest to deliberately inducing the disease. Photodynamic therapy, used for actinic keratoses and sometimes marketed for acne and "photorejuvenation," works by painting the skin with aminolevulinic acid or its methyl ester. The skin converts it to protoporphyrin IX, and a blue or red light then activates it. In other words, it manufactures a local porphyrin overload on purpose. The prescribing information for the FDA-approved ALA products lists porphyria as a contraindication. Our piece on actinic keratoses and photodynamic therapy covers alternatives such as topical fluorouracil, which do not depend on porphyrin chemistry.

Then the light sources:

  • Blue LED panels (typically around 415 nanometers) for acne sit almost exactly on the porphyrin absorption peak. They are a reasonable option in ordinary skin and a poor one in a patient with EPP or active PCT. The broader evidence on these panels is covered in our piece on red light and LED therapy.
  • Intense pulsed light (IPL) is broadband, and its lower edge is set by a cutoff filter. Filters vary by device and setting, and the shorter ones let through light close to the Soret band. In a patient with a cutaneous porphyria, that is a concrete reason to decline IPL for sun spots or redness rather than adjust settings and hope. Our pieces on lasers for sun spots and pigmentation and vascular lasers for facial redness describe the device options that IPL competes with.
  • Longer-wavelength lasers (the 1064-nanometer Nd:YAG, diode lasers, fractional erbium and CO2 resurfacing) are not absorbed by porphyrins to any meaningful degree. That does not make them automatically safe. PCT skin is fragile, heals slowly, scars easily, and is about to spend weeks healing in a world full of visible light. Published experience in porphyria patients is limited to case reports and small series, so any resurfacing decision belongs with a dermatologist who knows the patient's disease activity. The general tradeoffs are laid out in our piece on ablative versus non-ablative laser resurfacing.

The extra facial hair of PCT deserves its own note, because patients often arrive asking for laser hair removal. The hypertrichosis in PCT usually improves once the porphyria itself is treated, typically with scheduled phlebotomy to lower liver iron or low-dose hydroxychloroquine, prescribed by a hematologist or hepatologist. Treating the hair first is treating the symptom while the cause continues to damage the skin. The same logic applies to the dark patches and the scarring: control the disease, wait for the skin to settle, then reassess what cosmetic work is still wanted. A patient in active flare is a poor candidate for almost any elective skin procedure.

EPP patients raise a separate cosmetic wrinkle. The FDA approved afamelanotide in 2019, a small implant placed under the skin roughly every two months that increases the time adults with EPP can spend in light without pain. It works by stimulating melanin, so it darkens the skin and can darken freckles and moles. A clinician evaluating pigment, planning a peel, or examining moles needs to know about the implant, and a patient on it should not be sold a pigment-lightening program that works against a treatment their hematologist prescribed.

Sun protection after any procedure needs to be rethought too. Mineral sunscreens with zinc oxide and titanium dioxide, especially tinted versions containing iron oxides, block more visible light than clear chemical filters. Clothing, hats, and shade matter more than the SPF number, because SPF measures ultraviolet burning and says nothing about the violet light that matters here. Our pieces on scar care after plastic surgery and on albinism and cosmetic surgery cover sun discipline in other high-risk skin; porphyria adds the visible-light layer on top.

The operating room problem: surgical lights, skin fragility, and tape

The short answer: in severe EPP, prolonged exposure to surgical lamps has caused documented burns of the skin and even of exposed internal tissue, so the surgical team should plan filtered or limited lighting and covered skin, while in PCT the chief operating room risk is skin that blisters and tears under tape, adhesive dressings, and shear.

Surgical lights are bright, close, and on for hours. Most modern units are LED and emit very little ultraviolet, but they emit plenty of visible light, including the violet-blue end of the spectrum. The clearest documentation comes from liver transplantation in EPP, where patients have suffered phototoxic burns of the skin and injury to exposed abdominal organs under the operating lights. That literature led to the practice of covering surgical lamps with yellow filters that block the shorter wavelengths, limiting exposure time, and keeping all skin outside the field draped.

A three-hour breast augmentation is not a liver transplant, and most EPP patients undergoing short procedures will not burn. But the steps that prevent the problem are inexpensive and unglamorous, and the cost of skipping them lands on the patient's skin. A reasonable plan for a patient with EPP or XLP includes:

  • Telling the anesthesia and nursing team in advance, in writing, so it is part of the plan rather than a remark at the bedside.
  • Asking whether yellow filters are available for the overhead lights, and if not, keeping the lamps off until needed and directed only at the field.
  • Draping all exposed skin outside the operative area, including the face during long cases.
  • Positioning the recovery bay away from bright windows, and remembering that the drive home in daylight counts as exposure.

PCT patients, and VP and HCP patients with skin involvement, face a different hazard. Their skin blisters and erodes with minor friction. Adhesive tape on the forearm for an IV, electrode pads, the strip securing a breathing tube, a blood pressure cuff cycling for hours, and adhesive wound dressings all shear the top layer of skin. Silicone-based tapes, padding under cuffs, careful removal technique, and non-adhesive dressings reduce the damage. Slow healing in PCT skin is also a reason to discuss incision placement and the realistic scar result, which we cover more generally in our piece on wound dehiscence after cosmetic surgery.

Then there is the setting itself. A patient who needs filtered lights, a written drug plan, and a recovery team that knows what an acute attack looks like should be operated on in an accredited facility with an anesthesiologist, not in a procedure room at a med spa. That is the point of our pieces on outpatient facility accreditation and hospital privileges for cosmetic surgeons. For a porphyria patient, those credentials are not abstractions. They decide whether anyone in the building knows where to find hemin at night.

Acute porphyria: fasting, hormones, and the anesthesia drug list

The short answer: in acute intermittent, variegate, and hereditary coproporphyria, the surgical risk is an attack triggered by porphyrinogenic drugs, prolonged fasting, low calorie intake, alcohol, smoking, progesterone, infection, and physical stress, so the plan should check every drug against a porphyria drug database, keep carbohydrate intake steady, and arrange in advance for intravenous hemin if an attack begins.

The mechanism ties all the triggers together. The first enzyme in heme production, ALA synthase, is ramped up whenever the liver needs more heme. Many drugs induce liver enzymes of the cytochrome P450 family, which consume heme, which signals the liver to make more, which floods the blocked pathway with ALA and PBG. Fasting turns on the same switch through a different route. Progesterone does it too, which is why many women with AIP have attacks in the second half of their menstrual cycle.

Each of those triggers shows up around elective surgery.

Fasting and crash dieting. Preoperative fasting is necessary, but it should be as short as current anesthesia guidelines allow, and the case should be scheduled early in the day. Many anesthesiologists give carbohydrate-containing intravenous fluids during and after surgery for these patients. The bigger risk is often weeks earlier: the patient who starves herself to "get to goal weight" before a tummy tuck or liposuction. A rapid-weight-loss plan is a classic attack trigger. So are the very low intakes that some patients reach on appetite-suppressing medications, which is one more reason to read our piece on GLP-1 drugs before plastic surgery carefully and to involve the porphyria specialist before starting one.

Hormones. Combined birth control pills, progestin-only methods, and some hormone therapies can trigger acute attacks, and estrogen is a known driver of PCT. A patient who started a new hormonal method in the months before surgery and then has severe abdominal pain after the operation deserves the porphyria question asked out loud.

Alcohol and smoking. Both provoke acute attacks, and alcohol is a major driver of PCT. Our pieces on alcohol before cosmetic surgery and smoking cessation timelines give the general case; for porphyria patients, the case is stronger.

The drug list. This is where expertise matters most and improvisation is most dangerous. The American Porphyria Foundation and the European Porphyria Network maintain drug safety databases, built with the Norwegian Porphyria Centre (NAPOS), that classify individual medications as safe, probably safe, possibly porphyrinogenic, or porphyrinogenic. Some well-established points:

  • Barbiturates are classic triggers and are avoided. Several anticonvulsants, including phenytoin and carbamazepine, are also porphyrinogenic, which overlaps with issues in our piece on epilepsy and cosmetic surgery.
  • Propofol is widely regarded as safe for induction and sedation in acute porphyria, and common opioids such as morphine and fentanyl are generally considered acceptable.
  • Among antibiotics, sulfonamides such as trimethoprim-sulfamethoxazole and rifampin are on the avoid list, while cefazolin, the usual surgical antibiotic, is generally regarded as safe.
  • The status of some anesthetic adjuncts, sedatives, antiemetics, and pain relievers varies by agent and by database. That is the reason the anesthesiologist should check every drug individually rather than rely on memory or a general rule about a drug class.

Local anesthesia deserves a sentence of its own because cosmetic surgery uses so much of it. The common amide local anesthetics are generally listed as acceptable, but the very large total doses used in tumescent liposuction are a different situation from a dental block. A patient with an acute porphyria planning large-volume liposuction should have the anesthetic plan reviewed against the databases and with their porphyria specialist, not assumed safe because "it is only local." The same principle applies to everything else the patient takes: herbal products and supplements are poorly studied in porphyria, and our supplements stop list is a reasonable starting point for clearing the cabinet before surgery.

Givosiran and hemin. Patients with frequent attacks may be on givosiran, an RNA-interference drug approved by the FDA in 2019 that lowers ALA synthase production in the liver and markedly reduces attacks. It can raise liver enzymes and affect kidney function, so recent labs belong in the preoperative file. Intravenous hemin (sold in the United States as Panhematin) is the treatment for an acute attack. A hospital or surgery center that agrees to operate on a patient with active acute porphyria should know in advance how it would obtain hemin quickly.

When an attack looks like a surgical complication

The short answer: an acute porphyria attack after surgery causes severe abdominal pain, vomiting, a racing heart, high blood pressure, low sodium, confusion, and dark urine, which can be mistaken for a bleed, a bowel injury, or ordinary postoperative pain, and the specific test is a spot urine porphobilinogen measured during symptoms.

This is the scenario that worries porphyria specialists most. A patient has a tummy tuck. On the second day she has escalating abdominal pain out of proportion to the incision, nausea, constipation, a fast pulse, and rising blood pressure. Every one of those is also a reasonable sign of a surgical problem, and every one is also on the list of standard postoperative complaints. The natural response is more opioid, an antiemetic, perhaps a laxative, perhaps a scan. If the patient has acute porphyria and the team does not think of it, she may also receive a drug that worsens the attack, and the delay allows a neurological attack to progress.

Some features help separate the two. Attack pain is often poorly localized and out of proportion to what an examination of the abdomen finds. Low sodium, from inappropriate secretion of antidiuretic hormone, is common in attacks and can cause seizures. Urine may darken to red or brown on standing. Anxiety, insomnia, confusion, or hallucinations can appear. Muscle weakness, especially in the arms and shoulders, is a late and serious sign. Postoperative confusion has many causes, which we discuss in our piece on brain fog and delirium after anesthesia, but porphyria belongs on the list in a known carrier.

The specific test is a spot urine porphobilinogen, ideally measured during symptoms, because levels rise sharply in an attack. A patient with known acute porphyria should leave the preoperative visit with a written emergency letter naming the diagnosis, the treating specialist, safe and unsafe drug classes, and the request for urine PBG and hemin if symptoms appear. The American Porphyria Foundation encourages patients to carry such a card or letter for exactly this situation. It helps most when the patient is in an emergency room far from the surgeon, which is common for patients who travel for cosmetic surgery.

The liver and kidneys belong in the conversation too. People with long-standing acute hepatic porphyria have higher rates of chronic kidney disease, high blood pressure, and liver cancer than the general population, and guidelines recommend periodic liver cancer surveillance for many adults with these conditions. EPP can damage the liver in a minority of patients, and PCT is closely tied to liver iron, hepatitis C, and alcohol. Our pieces on fatty liver disease and cosmetic surgery, hemochromatosis and cosmetic surgery, and chronic kidney disease before cosmetic surgery cover how organ function changes the surgical plan. A PCT patient who has never been tested for hepatitis C, HIV, or HFE variants should be, and that workup comes before the cosmetic work, not after.

The blistering skin forms also get mistaken for other things, in both directions. PCT on the hands can be confused with other blistering diseases, such as those we cover in our piece on pemphigus vulgaris and cosmetic procedures, and light sensitivity on the face can be lupus rather than porphyria, a distinction our piece on cosmetic surgery with autoimmune disease touches on. Pseudoporphyria, a PCT lookalike caused by certain medications (including some NSAIDs such as naproxen), tanning beds, and kidney failure, produces similar blisters with normal porphyrin levels. The point is not that a cosmetic provider should make these diagnoses. It is that a provider who sees blistering, scarring, and hair growth on sun-exposed skin should stop and refer before treating, rather than reach for the IPL handpiece.

The honest summary

Porphyria is rare enough that most cosmetic practices will see it only a handful of times, and serious enough that those handful of times matter. The first job is to identify which porphyria a patient has, because the hazards in the two families barely overlap. In PCT, EPP, and the other skin forms, light is the enemy: photodynamic therapy is contraindicated, blue LED panels and short-filter IPL target the very wavelength porphyrins absorb, and the operating lamp itself deserves a plan in EPP. PCT also demands that the underlying disease be found and treated, including its links to alcohol, iron, hepatitis C, HIV, and estrogen, before anyone treats the spots, the scars, or the extra hair.

In acute intermittent porphyria and its relatives, the threat is an attack provoked by the ordinary machinery of elective surgery: fasting, pre-surgery dieting, hormonal contraception, alcohol, smoking, stress, and drugs that have not been checked against a porphyria database. Those risks are manageable. Patients with well-controlled acute porphyria have elective operations safely when the anesthesiologist checks every drug, carbohydrate intake stays steady, the facility can get hemin, and everyone on the team knows that severe abdominal pain on day two might not be a surgical complication.

The patients who get hurt are not usually the ones with the most severe disease. They are the ones whose diagnosis was a single line on an intake form that nobody read twice. If you have porphyria, say the type out loud, bring the specialist's letter, and walk away from any provider who treats it as a footnote.